DEF 14A

Company

AYTU BIOPHARMA, INC

Filed

June 16, 2017

Period of Report

July 26, 2017

Accession Number

0001144204-17-032816

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →